Core Scientific, Inc. (CORZ) Reports Q3 Loss, Misses Revenue Estimates

Core Scientific, Inc. Financial Performance - Core Scientific, Inc. reported a quarterly loss of $0.46 per share, which was better than the Zacks Consensus Estimate of a loss of $0.85, representing an earnings surprise of +45.88% [1] - The company posted revenues of $81.1 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 24.33%, and down from $95.35 million year-over-year [2] - Over the last four quarters, Core Scientific has surpassed consensus EPS estimates four times, but has only topped revenue estimates once [2] Stock Performance and Market Outlook - Core Scientific shares have increased approximately 28.5% since the beginning of the year, outperforming the S&P 500's gain of 14.6% [3] - The future stock price movement will largely depend on management's commentary during the earnings call and the earnings outlook [3][4] - The current consensus EPS estimate for the upcoming quarter is -$0.82 on revenues of $130.45 million, and for the current fiscal year, it is $1.07 on revenues of $396.77 million [7] Industry Context - The Financial - Miscellaneous Services industry, to which Core Scientific belongs, is currently ranked in the top 31% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Core Scientific's stock performance [5]